` Comparison: BM8 vs EPE - Alpha Spread

BM8
vs
E
EPE

Over the past 12 months, BM8 has outperformed EPE, delivering a return of -18% compared to the EPE's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
BM8
EPE
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

BM8 Intrinsic Value
73.35 EUR
Undervaluation 31%
Intrinsic Value
Price
E
EPE Intrinsic Value
Not Available
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Biomarin Pharmaceutical Inc
XBER:BM8
50.68 EUR
E
Epizyme Inc
F:EPE
559 EUR
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
BM8, EPE

BM8
EPE
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Biomarin Pharmaceutical Inc
Revenue
E
Epizyme Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
BM8, EPE

BM8
EPE
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Biomarin Pharmaceutical Inc
XBER:BM8
E
Epizyme Inc
F:EPE
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

BM8
81.3%
EPE
75.6%

Operating Margin

BM8
20.2%
EPE
-370.1%

Net Margin

BM8
16.8%
EPE
-391.9%

FCF Margin

BM8
26.7%
EPE
-394.1%

ROE

BM8
9.1%
EPE
-877.5%

ROA

BM8
7.2%
EPE
-67.4%

ROIC

BM8
8.4%
EPE
-181.7%

ROCE

BM8
9.7%
EPE
-72.5%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
BM8, EPE

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
BM8, EPE

Loading
BM8
EPE
Difference
www.alphaspread.com

Performance By Year
BM8, EPE

Loading
BM8
EPE
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare BM8 to other stocks
Custom
Choose any stock to compare
Unlock Full Access to Alpha Spread
Create Free Account